Craft

Bionik Laboratories

Stock Price

$0.1

2024-06-17

Market Capitalization

$12

2024-06-17

Revenue

$1.8 M

FY, 2023

Bionik Laboratories Summary

Company Summary

Overview
Bionik Laboratories is a medical device and robotics company developing transformational robotic rehabilitation technologies for individuals with neurological disorders. The Company is dedicated to providing individuals with restricted mobility an improvement in overall health, comfort, accessibility, and quality of life through the commercialization of its proprietary products. The Company’s lead program, ARKE is the most comprehensive lower-body exoskeleton that allows paraplegics and as well as other wheelchair users the ability to rehabilitate through walking. Currently, in clinical development, ARKE will initially be used in a rehabilitation environment, with the goal of being made available for home use.
Type
Public
Status
Active
Founded
2009
HQ
Toronto, CA | view all locations
Website
http://www.bioniklabs.com/
Cybersecurity rating
Sectors

Key People

  • Michal Prywata
  • Andre Auberton-Herve, Chairman of the Board

    • Richard Russo

      Richard Russo, President and CEO

    • Remi Gaston-Dreyfus, Director

      LocationsView all

      2 locations detected

      • Toronto, Ontario HQ

        Canada

        483 Bay St

      • Watertown, MA

        United States

        80 Coolidge Hill Rd

      Bionik Laboratories Financials

      Summary Financials

      Revenue (FY, 2023)
      $1.8M
      Gross profit (FY, 2023)
      $989.9K
      Net income (FY, 2023)
      ($4.9M)
      Cash (FY, 2023)
      $400.0K
      EBIT (FY, 2023)
      ($4.8M)
      Enterprise value
      ($143.5K)

      Footer menu